Imaging neurochemical endophenotypes: Promises and pitfalls

Pharmacogenomics

Volumn 2, Issue 3, 2001, Pages 223-237

  Martinez, D ^a   Broft, A ^a   Laruelle, M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

D2 receptor; Dopamine transporter; Genetics; PET; Polymorphism; Serotonin transporter; SPECT

Indexed keywords

ALCOHOL; AMPHETAMINE; ANTIDEPRESSANT AGENT; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRACER;

ALCOHOLISM; AUTOPSY; BRAIN FUNCTION; BRAIN REGION; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; DRUG DESIGN; DRUG TARGETING; GENE EXPRESSION; GENE FUNCTION; GENETIC CODE; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMAGING; MENTAL DISEASE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PROMOTER REGION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VARIABLE NUMBER OF TANDEM REPEAT;

BRAIN CHEMISTRY; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MENTAL DISORDERS; NERVE TISSUE PROTEINS; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034846033     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.2.3.223     Document Type: Review

References (164)

1. Schizophrenia: Genes and environment
2. Genetics of the risk for alcoholism
3. Serotonin transporter candidate gene studies in affective disorders and personality: Promises and potential pitfalls
4. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease
5. No difference in cerebral glucose metabolism in patients with Alzheimer's disease and differing apolipoprotein E genotypes
6. Longitudinal SPECT study in Alzheimer's disease: Relation to apolipoprotein E polymorphism
7. Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer's disease
8. Apolipo-protein E Type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease
9. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E
10. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
11. Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression and chromosomal localization
12. Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter
13. Allelic variation of human serotonin transporter gene expression
14. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
15. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders
16. Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells
17. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents
18. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets
19. Role of the serotonin transporter promoter polymorphism in anxiety-related traits
20. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample
21. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior
22. Association between serotonin transporter gene polymorphism and anxiety-related traits
23. Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population
24. Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese
25. Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs
26. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance
27. The serotonin transporter gene and peer-rated neuroticism
28. An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms
29. Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population
30. Role of the serotonin transporter gene in temperament and character
31. Neuroticism and polymorphisms in the serotonin transporter gene
32. Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism
33. No association between serotonin transporter gene polymorphisms and personality traits
34. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects
35. Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder
36. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders
37. Bipolar disorder and the serotonin transporter gene: A family-based association study
38. Serotonin transporter gene (HTTLPR) is not in linkage disequilibrium with prepubertal and early adolescent bipolarity
39. Serotonin transporter gene and risk for bipolar affective disorder: An association study in Spanish population
40. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders
41. Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide
42. Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders
43. Serotonin transporter gene polymorphisms, alcoholism and suicidal behavior
44. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide
45. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims
46. Evidence of linkage between the serotonin transporter and autistic disorder
47. Serotonin transporter (5-HTT) gene variants associated with autism?
48. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder
49. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder
50. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene
51. Cocaine, ethanol and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels
52. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence
53. High ethanol tolerance in young adults is associated with the low-activity variant of the promoter of the human serotonin transporter gene
54. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects
55. A family-based analysis of whether the functional promoter alleles of the serotonin transporter gene HTT affect the risk for alcohol dependence
56. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
57. 2C and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: A pilot study
58. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease
59. The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease
60. Promoter polymorphism of the 5-HT transporter and Alzheimer's disease
61. Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients
62. Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: No evidence for an association
63. No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus
64. 123I]3β-(4-Iodophenyl)tropan-2β-carboxylic acid methyl ester (RTI-55), a unique cocaine receptor ligand for imaging the dopamine and serotonin transporters in vivo
65. 123I]2β-carbomethoxy-3β-(4-iodophenyl)tropane (β-CIT): High affinity SPECT radiotracer of monoamine reuptake sites in brain
66. 123I]beta-CIT: Pharmacological characterization of brain uptake in nonhuman primates
67. 123I] beta-CIT binding to dopamine transporters in healthy human subjects
68. Beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
69. Prediction of dopamine transporter binding availability by genotype: A preliminary report
70. 11C](+)McN5652
71. 11C]DASB
72. Dopamine- and noradrenaline-containing neurone systems: Their anatomy in the rat brain
73. From motivation to action: Functional interface between the limbic system and the motor system
74. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
75. Human dopamine transporter gene: Coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations
76. 3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor ciliary neurotrophic factor (CNTF))
77. Association of attention-deficit disorder and the dopamine transporter gene
78. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
79. Association and linkage of the dopamine transporter gene and attention- deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity
80. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
81. 4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
82. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia
83. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium
84. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene
85. Evidence suggesting the role of specific genetic factors in cigarette smoking
86. A genetic association for cigarette smoking behavior
87. Association of smoking and personality with a polymorphism of the dopamine transporter gene: Results from a community survey
88. 2 receptor (DRD2) and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB)
89. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse
90. Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders
91. Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees
92. No evidence for linkage or association between the dopamine transporter gene and schizophrenia in a French population
93. The dopamine transporter protein gene (SLC6A3): Primary linkage mapping and linkage studies in Tourette syndrome
94. Variability and validity of polymorphism association studies in Parkinson's disease
95. Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment
96. Dopamine transporter density in patients with attention deficit hyperactivity disorder
97. Genotype influences in vivo dopamine transporter availability in human striatum
98. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans
99. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans
100. 11C]raclopride in the human brain
101. SPECT imaging of striatal dopamine release after amphetamine challenge
102. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
103. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects
104. 2 receptor gene is located on chromosome 11 at q22- q23 and identifies a TaqI RFLP
105. 2 receptor gene
106. 2 receptor gene is associated with schizophrenia
107. -141C Ins/Del promoter polymorphism, in European-American, African-American and Japanese subjects
108. 2 receptor gene in alcoholism
109. 2 dopamine receptor gene with severe alcoholism
110. 2 receptor gene TaqI A RFLP in Japanese
111. 2 receptor genes
112. 2 dopamine receptor gene and alcoholism
113. 2 dopamine receptor A1 allele with alcoholism: Medical severity of alcoholism and type of controls
114. Haplotypes at the DRD2 locus and severe alcoholism
115. 2 receptor gene and alcoholism
116. 2 dopamine receptor gene (DRD2) and alcoholism
117. 2 dopamine receptor locus. Studies of association and linkage
118. 2 receptor gene
119. 2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States
120. 2-receptor gene polymorphisms in Scandinavian chronic alcoholics
121. 2 receptor gene TaqI A1 polymorphism and alcoholism in a Mexican population
122. 2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism
123. 2 dopamine receptor locus (DRD2) in alcoholics and controls
124. 2 receptor (DRD2) with alcoholism
125. 2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: No association with phenotype or severity of phenotype
126. 2 dopamine receptor gene with cocaine dependence
127. 2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: Enhanced frequencies in psychostimulant-preferring polysubstance abusers
128. The D(2) dopamine receptor A(1) allele and opioid dependence: Association with heroin use and response to methadone treatment
129. 2 receptor gene: A genetic risk factor in substance abuse
130. 2 dopamine receptor gene and cigarette smoking: A reward gene?
131. 2 receptor (DRD2) gene: A genetic risk factor in smoking
132. 2 receptor gene variants: Association and linkage studies in impulsive-addictive-compulsive behaviour
133. 2 dopamine receptor gene and obesity
134. 2 dopamine receptor TaqI B1 RFLP with severe alcoholics
135. 2 dopamine receptor TaqI B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers
136. 2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans
137. 2 receptor gene and tardive dyskinesia in schizophrenia
138. 2 receptor polymorphism at the TaqI A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients
139. 2 receptor locus as a modifying gene in neuropsychiatric disorders
140. 2 receptor gene promoter and schizophrenia
141. 2 receptor gene and schizophrenia
142. 2 receptor gene: Lack of association with schizophrenia and bipolar affective disorder. Short communication
143. 2 receptor promoter polymorphism: No association with schizophrenia
144. -141C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population
145. 2 receptor gene and alcoholism
146. 2 receptor gene (DRD2) in three distinct Taiwanese populations
147. 2 receptor gene and alcohol dependence in the German population
148. 2 dopamine receptor gene with receptor- binding characteristics in alcoholism
149. 2 receptor binding in the human striatum associated with the A1 allele
150. 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence
151. Decreases in dopamine receptors but not in dopamine transporters in alcoholics
152. 2 receptors availability is associated with reduced frontal metabolism in cocaine abusers
153. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
154. 2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
155. Brain dopamine and obesity
156. 2 dopamine receptor polymorphism
157. 2 receptor availability in healthy volunteers
158. 2 receptor gene
159. 2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
160. 2 receptor density in vivo
161. Models and methods for derivation of in vivo receptor parameters with PET and SPECT reversible radiotracers
162. 11C]WAY 100635 and positron emission tomography in humans
163. 2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptic
164. 2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography